New York, New York, United States
As an operating partner at ARCHIMED, a leading global private equity firm focused exclusively on healthcare industries, I leverage my expertise in financial and strategic management to support the growth and value creation of our portfolio companies. With over 20 years of experience in accounting, M&A, and SOX, I advise senior management and board of directors on resolving economic and financial issues, facilitating mergers and acquisitions, and ensuring compliance and governance. I am also the founder of White Star Consulting, an advisory firm that provides customized services to clients in need of strategic financial leadership to achieve their business goals. I assist clients to design, implement, and manage the right financial strategy, acting as an interim or fractional CFO. Additionally, I serve as an advisor to the CEO of Limula, which offers a modular solution for on-demand and at-scale manufacturing of cell therapies in a single device. I am passionate about building positive relationships with interdepartmental teams, clients, and key stakeholders, and collaborating to realize strategic business goals. I am also a proud member of the Biotech and Medtech CFO’s club, and a marathon runner.
ARCHIMED is a leading, global private equity firm focused exclusively on healthcare industries. ARCHIMED international team combines investment, medical, scientific and operational expertise to serve as a strategic and financial partner to European and North American healthcare enterprises. Ultimately, ARCHIMED strives to build bigger and better healthcare businesses to deliver improved health outcomes and help people across the world.
After Big 4 in Europe and in the US, Merger & Acquisition and CFO experiences in US/European public and private companies, White Star Consulting provides customized services to companies in need of strategic financial leadership to achieve their business goals. Assist clients to design, implement and manage the right financial strategy to deliver value creation. Acting as interim/fractional CFO.
Pioneering Pancreatic Cancer Care Through First-in-Class Discovery Engine. Value Proposition: Groundbreaking Science to target Pancreatic Cancer through Complementary Mechanisms
Turn French innovative healthcare organisations into world leaders